Lawsuits, Black Boxes & Hallucinations: Navigating the Complexity of Copyright & AI
Learn to choose, design and deploy copyright-compliant AI-powered solutions for Medical Affairs Publications.
Entries by Jalene Kaiser
Safeguarding Scientific Rigor in the Critical Evaluation of Literature: Enabling Rapid Appraisal with the CLEAR Framework
This paper presents the CLEAR framework as a way to maintain scientific rigor when rapidly appraising literature in the context of Medical Affairs
Leading in Times of Change: Part 2
On today’s MAPS “Elevate” episode, we’ll discuss how Medical Affairs leaders present experiences from the design and implementation of impact frameworks
Optimizing MSL-led Learning Journeys: An Omnichannel Perspective
The Medical, Legal, and Regulatory (MLR) review process is critical for ensuring compliance and accuracy in pharmaceutical and healthcare communications—but it’s often time-consuming and resource-intensive.
Turning Vision Into Value: Medical Affairs Impact in Practice
On today’s MAPS “Elevate” episode, we’ll discuss how Medical Affairs leaders present experiences from the design and implementation of impact frameworks
Through the Noise: How Medical Affairs Can Cut Content Waste and Improve Impact
Medical Affairs teams produce more content than HCPs can consume. This article by Costello Medical explores how to cut content waste through insight-led planning, modular design, smart omnichannel personalisation, and impact-focused measurement — translating efficiency into better scientific exchange and patient outcomes.”
2026 EMEA Annual Meeting: Zurich Linkedin
Zurich Linkedin page
Medical Insights Transformation in the Age of AI
How Medical Affairs teams can break free from insights bottlenecks using AI — moving from reactive reporting to proactive, curiosity-driven strategic intelligence.
Optimizing Non-Company Sponsored Research as Part of Integrated Evidence Generation: A Practical Overview to Ensure Strategic, Timely, Valuable Evidence
As the demand for increased levels of evidence grows, so too has the role of Non-Company Sponsored Research (NCSR). This position paper by the MAPS Evidence Generation Domain provides key considerations to ensure NCSR delivers strategic value.